Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
about
The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal CancerSerrated pathway in colorectal carcinogenesisSerrated polyps and their alternative pathway to the colorectal cancer: a systematic reviewActivity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition.Methylome profiling reveals functions and genes which are differentially methylated in serrated compared to conventional colorectal carcinoma.Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid CarcinomaExpression of PI3Kp110α and PI3Kp110β in the colorectal conventional adenoma, serrated lesions and adenoma with canceration and their significanceSessile serrated adenomas: high-risk lesions?Clinical impact and network of determinants of tumour necrosis in colorectal cancerThe serrated pathway to colorectal carcinoma: current concepts and challenges.Colorectal serrated pathway cancers and precursors.Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.Serrated tubulovillous adenoma of the large intestine.Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma.BRAF mutation is associated with the unique morphology of traditional serrated adenoma of the colorectum.Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma.A clinicopathological and molecular analysis of 200 traditional serrated adenomas.Extent of field change in colorectal cancers with BRAF mutation.Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.What can molecular pathology offer for optimal decision making?HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer.Annexin A10 is a marker for the serrated pathway of colorectal carcinoma.Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma.
P2860
Q26796255-5E08113C-E061-4848-BB42-DB3B11845520Q27010553-7D5950D3-F020-4431-978B-BA2B1888D6A1Q28081212-28D76079-5E7A-47AA-902A-E73ADB2DED03Q33412380-53856022-281B-4323-B5C8-8C7ED9948A28Q33732199-EA3FB8B2-CFD2-418D-9D38-B94F233CF6EDQ33798773-E73275EC-9369-4DFC-B289-CB47E8EB50B9Q33862088-EFC73E86-55C3-4782-BD97-AA5B175EA6BCQ34613174-0FE5E76A-9779-4E8C-9581-2AE8F74D19DEQ36070870-A7305863-CE6A-463E-B717-2D421AB2533FQ36468764-70429033-143A-4EA8-AEEE-FCE7A9CA45C6Q36511817-C80176C1-B477-44DB-A3BB-2D8B104284E6Q36693976-1220C6C5-9908-4F7D-A00B-85CFB9FE061FQ37174042-2CFE4997-FBDC-4FF9-A4FD-5FBED6C336E2Q38075894-1C2053EB-CB62-4736-803F-9EB8F4AF7E1FQ38255029-3DF27A55-D031-464A-B511-0726FEC43F91Q40720854-765575AD-4A4F-493B-AF0D-3BDA561B34C2Q41545966-F3A7939C-E373-44A0-B901-504BED8FAB36Q43502334-455B8C3C-EE65-46F8-90B3-CF45DB076F34Q47740800-4535937B-3D6E-4D5D-BEFC-C23F642BBEE4Q50001605-DBCF4608-DDCD-42AE-B875-3ACAC6F5FC50Q51113698-93F8F246-6107-4B26-991C-BBB7A4DACB5DQ51134123-816A5FA1-7A78-4707-B4D0-72CEBC574F9AQ51135450-B4291EFB-E655-4B9F-812F-6A284C8565AAQ51554436-566B4A89-5DC9-4A77-8F69-5E8E39E7E0D3Q51638859-534671F0-43BB-4658-B527-CC15A429D0B2Q54309791-DF5B943A-D038-45E0-9371-970E3CAD276EQ54369974-8CA1A6CC-A5D3-4E46-A7E6-964679F5F995
P2860
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
@ast
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
@en
type
label
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
@ast
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
@en
prefLabel
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
@ast
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
@en
P2093
P2860
P50
P1433
P1476
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma
@en
P2093
Laura Ylitalo
Markus J Mäkinen
Päivi Sirniö
Rami Kuivila
Tiina Kantola
P2860
P304
P356
10.1111/J.1365-2559.2011.03821.X
P577
2011-04-04T00:00:00Z